In a false advertising case in California, a federal appeals court ruled certain claims brought by the plaintiff were pre-empted due to the clear distinction between "structure/function" and "disease" claims in the Federal Food, Drug & Cosmetic Act.
FDA continues to cite dietary supplement facilities for regulatory infractions related to establishing product specifications—and own-label distributors remain partly to blame.
The Arizona State Board of Pharmacy has moved to repeal a regulation over dietary supplements following concerns expressed by several industry trade groups and an attorney who represented a marketer of herbal supplements.
Physician Pieter Cohen of Harvard Medical School and several industry sources weighed in on a decrease in FDA cGMP inspections in fiscal year 2018.
Passage of the Farm Bill this week in Congress marked a watershed event for a crop planted centuries ago by America’s founding fathers, paving the way for increased commercialization of hemp products and services without the threat of interference...
Marketers of dietary supplements should follow several federal rules and guidelines when forging relationships with celebrities and others to endorse their products.
A company selling male enhancement products has devised a strategy to target competing products adulterated with undeclared drugs: sue the retailers that sell them.
Two California residents and an associated company importing ingredients into the United States have been indicted for a smuggling scheme in which controversial substances, such as steroid precursors, ended up in products marketed as dietary...
FTC on Thursday announced that it is mailing nearly 16,600 checks to consumers who purchased dietary supplements that were deceptively marketed, including a product that claimed it could protect the brain against Alzheimer’s disease and dementia.
Under order from California appeals court to retry the suit, district judge issues injunctive but not monetary relief against company that sold SARMs in dietary supplements.
